OPSIS THERAPEUTICS
Live / Registered — Registered (as of 02 Jul 2024)
What this means for you
Registered since 02 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90027853
- Registration number
- 7434279
- Mark type
- Stylized text
- Filed
- 30 Jun 2020
- Published for opposition
- 30 Mar 2021
- Registered
- 02 Jul 2024
- Attorney of record
- Jason M. Hunt
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations derived from human stem cells for the treatment of ocular disorders; living tissue grafts for surgical implantation for the treatment of ocular disorders
- Class 010 — Medical apparatus: Implants comprising natural, non-living materials derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation
Owner
- Opsis Therapeutics, LLC, Madison, WI, US
- Opsis Therapeutics, LLC, Madison, WI, US
- Opsis Therapeutics, LLC, Madison, WI, US
Prosecution history
- 02 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 09 May 2024 — USE AMENDMENT FILED
- 09 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2024 — SOU EXTENSION 5 GRANTED
- 27 Nov 2023 — SOU EXTENSION 5 FILED
- 13 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Dec 2023 — NOTICE OF REVIVAL - E-MAILED
- 28 Dec 2023 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 28 Dec 2023 — NOTICE OF REVIVAL - E-MAILED
- 28 Dec 2023 — PETITION TO REVIVE-GRANTED